- Home
- DTCK vs IMRN Comparison
DTCK vs IMRN Comparison
Compare DTCK & IMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DTCK
- IMRN
- Stock Information
- Founded
- DTCK 1999
- IMRN 1994
- Country
- DTCK Singapore
- IMRN Australia
- Employees
- DTCK N/A
- IMRN N/A
- Industry
- DTCK Farming/Seeds/Milling
- IMRN Biotechnology: Pharmaceutical Preparations
- Sector
- DTCK Industrials
- IMRN Health Care
- Exchange
- DTCK Nasdaq
- IMRN Nasdaq
- Market Cap
- DTCK 12.0M
- IMRN 10.1M
- IPO Year
- DTCK 2023
- IMRN N/A
- Fundamental
- Price
- DTCK $0.62
- IMRN $1.72
- Analyst Decision
- DTCK
- IMRN Strong Buy
- Analyst Count
- DTCK 0
- IMRN 1
- Target Price
- DTCK N/A
- IMRN $5.00
- AVG Volume (30 Days)
- DTCK 42.0K
- IMRN 22.7K
- Earning Date
- DTCK 11-13-2024
- IMRN 05-06-2025
- Dividend Yield
- DTCK N/A
- IMRN N/A
- EPS Growth
- DTCK N/A
- IMRN N/A
- EPS
- DTCK 0.02
- IMRN N/A
- Revenue
- DTCK $159,836,000.00
- IMRN $4,048,286.00
- Revenue This Year
- DTCK N/A
- IMRN N/A
- Revenue Next Year
- DTCK N/A
- IMRN N/A
- P/E Ratio
- DTCK $28.63
- IMRN N/A
- Revenue Growth
- DTCK N/A
- IMRN 82.90
- 52 Week Low
- DTCK $0.40
- IMRN $1.60
- 52 Week High
- DTCK $1.73
- IMRN $2.87
- Technical
- Relative Strength Index (RSI)
- DTCK 44.73
- IMRN 46.67
- Support Level
- DTCK $0.48
- IMRN $1.64
- Resistance Level
- DTCK $0.62
- IMRN $1.91
- Average True Range (ATR)
- DTCK 0.08
- IMRN 0.16
- MACD
- DTCK 0.02
- IMRN 0.00
- Stochastic Oscillator
- DTCK 54.55
- IMRN 31.00
About DTCK Davis Commodities Limited
Davis Commodities Ltd is an agricultural commodity trading company based in Singapore which specializes in trading of three main categories of agricultural commodities namely sugar, rice, and oil and fat products. It distributes agricultural commodities to various markets, including Asia, Africa and the Middle East. The company also provides customers of commodity offerings with complementary, ancillary services such as warehouse handling and storage and logistics services. The Company operates across four main segments: the sale of sugar, rice, oil and fat products, and others. Among these, the sale of sugar stands out as the primary revenue generator, contributing significantly to the company's overall income.
About IMRN Immuron Limited
Immuron Ltd is a commercial and clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.